tiprankstipranks
Alterity Therapeutics (PRNAF)
OTHER OTC:PRNAF
US Market
PRNAF
Alterity Therapeutics
RESEARCH TOOLSreports

Alterity Therapeutics (PRNAF) Ratios

7 Followers

Alterity Therapeutics Ratios

PRNAF's free cash flow for Q4 2026 was AU$0.00. For the 2026 fiscal year, PRNAF's free cash flow was decreased by AU$ and operating cash flow was AU$0.00. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Jun 25Jun 24Jun 23
Liquidity Ratios
Current Ratio
 14.52 14.52 12.98 3.54 6.17
Quick Ratio
 14.52 14.52 12.98 3.54 6.17
Cash Ratio
 11.82 11.82 9.38 2.35 3.60
Solvency Ratio
 -7.07 -7.07 -3.34 -3.50 -3.04
Operating Cash Flow Ratio
 -7.14 -7.14 -3.24 -2.35 -4.57
Short-Term Operating Cash Flow Coverage
 -408.22 -408.22 0.00 -117.67 -186.94
Net Current Asset Value
AU$ 42.53MAU$ 42.53MAU$ 42.25MAU$ 13.61MAU$ 22.54M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 0.01 <0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.08 1.08 1.09 1.39 1.20
Debt Service Coverage Ratio
 -449.63 -449.63 0.00 -182.07 -164.39
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 <0.01 <0.01 0.00 <0.01 <0.01
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 1.31 1.31 2.26 0.64 0.89
Profitability Margins
Gross Profit Margin
0.00%0.00%97.66%94.67%92.72%
EBIT Margin
0.00%0.00%-269.57%-487.82%-449.82%
EBITDA Margin
0.00%0.00%-269.05%-484.15%-447.20%
Operating Profit Margin
0.00%0.00%-267.96%-487.69%-373.72%
Pretax Profit Margin
0.00%0.00%-222.10%-474.65%-349.87%
Net Profit Margin
0.00%0.00%-223.35%-475.79%-352.54%
Continuous Operations Profit Margin
0.00%0.00%-223.35%-475.79%-352.54%
Net Income Per EBT
87.00%87.00%100.56%100.24%100.76%
EBT Per EBIT
94.64%94.64%82.88%97.33%93.62%
Return on Assets (ROA)
-50.85%-50.85%-26.39%-99.48%-50.54%
Return on Equity (ROE)
-48.25%-54.77%-28.65%-138.60%-60.52%
Return on Capital Employed (ROCE)
-66.30%-66.30%-34.30%-141.53%-63.81%
Return on Invested Capital (ROIC)
-57.61%-57.61%-34.25%-139.37%-63.22%
Return on Tangible Assets
-50.85%-50.85%-26.39%-99.48%-50.54%
Earnings Yield
-23.91%-19.33%-18.99%-104.80%-81.24%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 1.38 0.99 0.45
Payables Turnover
 0.06 0.10 0.24 0.37 0.17
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 35.05 21.51 14.57
Asset Turnover
 0.00 0.00 0.12 0.21 0.14
Working Capital Turnover Ratio
 0.00 0.00 0.19 0.22 0.14
Cash Conversion Cycle
 -6.40K -3.54K -1.28K -622.75 -1.39K
Days of Sales Outstanding
 0.00 0.00 264.25 367.03 806.07
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 6.40K 3.54K 1.54K 989.79 2.20K
Operating Cycle
 0.00 0.00 264.25 367.03 806.07
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.10 -0.11 -0.09 >-0.01 >-0.01
Free Cash Flow Per Share
 0.00 0.00 -0.09 >-0.01 >-0.01
CapEx Per Share
 0.10 0.11 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.00 0.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -1.00 -1.00 -5.73M -2.20K -2.74K
Capital Expenditure Coverage Ratio
 -1.00 -1.00 -5.73M -2.20K -2.74K
Operating Cash Flow Coverage Ratio
 -116.42 -116.42 -73.66 -79.26 -95.23
Operating Cash Flow to Sales Ratio
 0.00 0.00 -2.11 -3.14 -5.12
Free Cash Flow Yield
0.00%0.00%-17.90%-69.11%-117.94%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -4.12 -5.23 -5.26 -0.95 -1.23
Price-to-Sales (P/S) Ratio
 0.00 0.00 11.76 4.54 4.34
Price-to-Book (P/B) Ratio
 2.32 2.83 1.51 1.32 0.74
Price-to-Free Cash Flow (P/FCF) Ratio
 0.00 0.00 -5.59 -1.45 -0.85
Price-to-Operating Cash Flow Ratio
 -4.39 -5.37 -5.59 -1.45 -0.85
Price-to-Earnings Growth (PEG) Ratio
 0.24 -0.33 0.08 0.11 -0.16
Price-to-Fair Value
 2.32 2.83 1.51 1.32 0.74
Enterprise Value Multiple
 -2.18 -2.96 -2.12 -0.30 -0.08
Enterprise Value
 60.75M 83.91M 30.97M 5.77M 1.43M
EV to EBITDA
 -2.15 -2.96 -2.12 -0.30 -0.08
EV to Sales
 0.00 0.00 5.69 1.44 0.37
EV to Free Cash Flow
 0.00 0.00 -2.70 -0.46 -0.07
EV to Operating Cash Flow
 -2.70 -3.73 -2.70 -0.46 -0.07
Tangible Book Value Per Share
 0.20 0.20 0.33 <0.01 <0.01
Shareholders’ Equity Per Share
 0.20 0.20 0.33 <0.01 <0.01
Tax and Other Ratios
Effective Tax Rate
 0.13 0.13 >-0.01 >-0.01 >-0.01
Revenue Per Share
 0.00 0.00 0.04 <0.01 <0.01
Net Income Per Share
 -0.11 -0.11 -0.09 >-0.01 >-0.01
Tax Burden
 0.87 0.87 1.01 1.00 1.01
Interest Burden
 0.95 0.95 0.82 0.97 0.78
Research & Development to Revenue
 0.00 0.00 2.65 4.64 3.37
SG&A to Revenue
 0.00 0.00 1.01 1.19 1.27
Stock-Based Compensation to Revenue
 0.00 0.00 0.18 0.22 0.25
Income Quality
 0.96 0.96 0.94 0.66 1.45
Currency in AUD